Xiaoxia Lu Selected Research

Xiaoxia Lu Research Topics

Disease

5	Inflammation (Inflammations) 01/2024 - 01/2017
5	COVID-19 12/2022 - 01/2020
5	Poisoning 03/2022 - 07/2018
4	Infections 01/2024 - 03/2010
3	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 01/2018
3	Neoplasms (Cancer) 11/2022 - 01/2016
3	Asthma (Bronchial Asthma) 03/2019 - 03/2018
3	Obstructive Sleep Apnea 08/2018 - 01/2018
2	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2016
1	Primary Immunodeficiency Diseases 01/2024
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2024
1	Viremia 01/2024
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2024
1	Nervous System Diseases (Neurological Disorders) 12/2023
1	Glioma (Gliomas) 01/2023
1	Liver Neoplasms (Liver Cancer) 01/2023
1	Respiratory Insufficiency (Respiratory Failure) 12/2022
1	COVID-19 related pediatric multisystem inflammatory disease 12/2022
1	Squamous Cell Carcinoma of Head and Neck 11/2022
1	Acute Lung Injury 01/2022
1	Fatty Liver 01/2022
1	Hyperglycemia 01/2022
1	Carcinogenesis 01/2022
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Sepsis (Septicemia) 01/2022
1	Neutropenia 08/2021
1	Thrombocytopenia (Thrombopenia) 08/2021
1	Coinfection 03/2021
1	Rheumatoid Arthritis 01/2021
1	Breast Neoplasms (Breast Cancer) 10/2020
1	Intussusception 09/2020
1	Human Influenza (Influenza) 09/2020
1	Mood Disorders (Mood Disorder) 02/2020

Drug/Important Bio-Agent (IBA)

4	CytokinesIBA 01/2022 - 03/2010
3	MicroRNAs (MicroRNA)IBA 11/2022 - 01/2017
3	C-Reactive ProteinIBA 09/2020 - 03/2019
3	Therapeutic UsesIBA 07/2018 - 12/2006
2	Immunoglobulins (Immunoglobulin)IBA 01/2024 - 01/2015
2	Proteins (Proteins, Gene)FDA Link 12/2023 - 03/2010
2	GlucocorticoidsIBA 12/2022 - 03/2019
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2018
2	RNA (Ribonucleic Acid)IBA 12/2021 - 01/2021
2	Colchicine FDA LinkGeneric 10/2021 - 08/2021
2	Nucleic AcidsIBA 03/2021 - 01/2020
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 03/2019
2	ThalliumIBA 07/2019 - 07/2018
2	Particulate MatterIBA 07/2018 - 03/2018
2	OvalbuminIBA 07/2018 - 03/2018
2	Complement System Proteins (Complement)IBA 01/2018 - 01/2018
2	Complement C3 (C3 Complement)IBA 01/2018 - 01/2018
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2024
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2024
1	Indicators and Reagents (Reagents)IBA 01/2024
1	Histone Deacetylases (Histone Deacetylase)IBA 12/2023
1	Histone Deacetylase 6IBA 06/2023
1	Circulating Tumor DNAIBA 01/2023
1	Hydroxyl RadicalIBA 01/2023
1	ErianinIBA 01/2023
1	Pyruvate CarboxylaseIBA 01/2023
1	FluorineIBA 01/2023
1	VaccinesIBA 12/2022
1	Intravenous Immunoglobulins (IVIG)FDA Link 12/2022
1	remdesivirIBA 12/2022
1	AntipyreticsIBA 12/2022
1	Oxygen (Dioxygen)IBA 12/2022
1	GoldIBA 11/2022
1	Transforming Growth Factor beta (TGF-beta)IBA 11/2022
1	ParaquatIBA 03/2022
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2022
1	Triglycerides (Triacylglycerol)IBA 01/2022
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2022
1	Promyelocytic Leukemia Zinc Finger ProteinIBA 01/2022
1	LipidsIBA 01/2022
1	ProteomeIBA 01/2022
1	DiarylheptanoidsIBA 01/2022
1	CholesterolIBA 01/2022
1	Thrombopoietin (c-mpl Ligand)IBA 08/2021
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 08/2021
1	25-hydroxyvitamin DIBA 01/2021
1	cyclic citrullinated peptideIBA 01/2021
1	Anti-Citrullinated Protein AntibodiesIBA 01/2021
1	hydroxide ionIBA 01/2021
1	VimentinIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Angiotensin-Converting Enzyme 2IBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 10/2020
1	salinomycinIBA 10/2020
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 10/2020
1	KynurenineIBA 10/2020
1	ProcalcitoninIBA 09/2020
1	Orexin ReceptorsIBA 02/2020
1	fibrin fragment D (D-dimer)IBA 01/2020

Therapy/Procedure

2	Therapeutics 11/2022 - 08/2018
2	Length of Stay 03/2021 - 03/2018
2	Continuous Positive Airway Pressure 08/2018 - 01/2018
1	Noninvasive Ventilation 12/2022
1	Cannula 12/2022
1	Immunotherapy 10/2020
1	Enema (Enemas) 09/2020
1	Patient Readmission 01/2020